chevron_left
Relapsed and Refractory MM Treatment
adjust
1. What is relapsed myeloma and refractory myeloma? Video
bookmark_border
2. What is progressive disease? Is it the same as relapse? Video
bookmark_border
3. What is a Biochemical vs Clinical Relapse? Video
bookmark_border
4. What are the cycles of relapse and remission in myeloma? Video
bookmark_border
5. Why do drugs stop working? Video
bookmark_border
6. Do individuals become refractory to a given drug or an entire class of drugs? Video
bookmark_border
7. What testing should be done at relapse? What is restaging? Video
bookmark_border
8. What are the goals of treatment at relapse? Video
bookmark_border
9. With relapsed myeloma, when should you modify current therapy change dosage? Video
bookmark_border
10. What are the NCCN Treatment Guidelines? What strategy should be used in selecting a therapy? Video
bookmark_border
11. Why is it important to be consulting with a myeloma specialist at relapse? Video
bookmark_border
12. What treatments are available for first relapse? Video
bookmark_border
13. What treatments should be considered in bortezomib/velcade refractory patients at first relapse? Video
bookmark_border
14. What are some possible monoclonal antibodies and MAB combinations to consider at first relapse? Video
bookmark_border
15. What are some newer therapies with different mechanisms of action to consider at first relapse? Video
bookmark_border
16. What does it mean to be triple class refractory? Video
bookmark_border
17. Is there a role for transplant if not used upfront or a second transplant at first relapse? Video
bookmark_border
18. What is the role of genomics at relapse? Video
bookmark_border
19. Are there any targeted approaches for specific genetic subsets that patients should ask about? Video
bookmark_border
20. How do you decide on an appropriate treatment at relapse with so many to choose from? Video
bookmark_border
21. When should a patient consider a clinical trial in relapse? Video
bookmark_border
22. With so many options available, at what point should a patient consider getting a second opinion? Video
bookmark_border
23. What FDA approved treatments are available treatments for patients with RRMM with received two or more prior lines of therapy? Video
bookmark_border
24. What is meant by t-cell redirecting therapy? Video
bookmark_border
25. Where should CAR-T cell therapy be positioned in RRMM approved and trials? Video
bookmark_border
26. Where should bispecific antibodies be positioned in RRMM? Video
bookmark_border
27. What factors should be considered when choosing between a CAR T cell therapy and a bispecific antibody therapy? Video
bookmark_border
28. What is a BCMA-directed Therapy? What are some FDA approved BCMA-directed therapies? Video
bookmark_border
29. Is there a role for conventional chemotherapy in the treatment of relapsed and refractory myeloma? Video
bookmark_border
30. Will an allogeneic transplant ever be considered at relapse? Video
bookmark_border
31. What are some promising investigational agents and novel therapies for relapsed/refractory patients? Video
bookmark_border
32. What is the role of supportive care throughout relapsed and refractory myeloma management? Video
bookmark_border
33. What is bone strengthening therapy? Video
bookmark_border
34. What are some tips for coping with the fear of relapse? Video
bookmark_border
35. What are the unmet needs and challenges in the relapsed/refractory myeloma setting? Video
bookmark_border
36. How can HealthTree help with assessing treatment options at relapse? Video
bookmark_border
37. What is Off-label Use of a Drug? Video
bookmark_border
38. What is Considered a Line of Therapy? Video
bookmark_border
39. (Guest Lecture): Immunotherapies | Experts Discuss Relapsed/Refractory Myeloma, Amyloidosis Video
bookmark_border
40. (Guest Lecture): Relapsed Refractory Multiple Myeloma - Krina Patel, MD, MSc | RT Irvine, CA Nov 5, 2022 Video
bookmark_border
41. (Guest Lecture): Amyloidosis | Experts Discuss Relapsed/Refractory Myeloma, Amyloidosis Video
bookmark_border
42. (Guest Lecture) When and How you Become Refractory to a Drug and How to Find the Best Next Treatment Video
bookmark_border
43. (Guest Lecture): Emerging Treatments | Experts Discuss Relapsed/Refractory Myeloma, Amyloidosis Video
bookmark_border
44. (Guest Lecture): September 2023 - Personalizing Options for Relapse/Refractory Patients Video
bookmark_border
45. (Guest Lecture): October 2023 - Personalizing Therapy for Each Relapsed/Refractory Myeloma Patient Video
bookmark_border
46. (Guest Lecture): March 2024 - The Bounty of Treatments for Early Relapsed Myeloma Video
bookmark_border
47. (Guest Lecture): March 2024 - Exploring the Myeloma Toolbox Video
bookmark_border![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}